Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial.

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial. JAMA Oncol. 2025 May 01; 11(5):492-501.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Chemoradiotherapy
Female
Head and Neck Neoplasms
Humans
Male
Middle Aged
Neoadjuvant Therapy
Paclitaxel

authors with profiles

John Cursio
Nicole Cipriani
Elizabeth Blair
Olga Pasternak-Wise
Ari Rosenberg
Mark Lingen
Daniel Haraf
Evgeny Izumchenko
Alexander Pearson
Nishant Agrawal
Everett Vokes
Aditya Juloori
Rohan Katipally